NCT06291818

Brief Summary

Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. With improvement in magnetic technology, however, that may change. Barmettler et al (2014) have demonstrated preliminary success of externally affixed magnets in closing both model and patient eyelids. As such, we hypothesize that magnetic devices can be used to treat corneal exposure by controlling eyelid position.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

April 17, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

May 13, 2024

Status Verified

May 1, 2024

Enrollment Period

8 months

First QC Date

January 26, 2024

Last Update Submit

May 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with success of a temporary magnetic system for tarsorrhaphy

    Use of a temporary magnetic system for tarsorrhaphy (MST) to provide adequate closure of the eyes for ultimate use in conditions causing lagophthalmos (a disorder in eyelid closure)

    through study completion, an average of 3 years

Study Arms (1)

Assess the performance of this novel eyelid closure device in vivo

OTHER

The primary goal of this study is to determine the feasibility and success of a temporary magnetic system for tarsorrhaphy (MST) to provide adequate closure of the eyes for ultimate use in conditions causing lagophthalmos (a disorder in eyelid closure). In this disorder, people are unable to sufficiently cover their cornea (the front of the eye), which can lead to dryness, infection, scarring and even blindness. Current therapies are invasive, involving local anesthesia and surgeries, and have a negative cosmetic impact.

Device: temporary magnetic system for tarsorrhaphy (MST)

Interventions

cutting-edge technology has produced smaller magnets with stronger magnetic fields, prompting experts to revisit the use of magnets to facilitate eyelid closure

Assess the performance of this novel eyelid closure device in vivo

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females ages 18-80 years old.
  • Patients with recent corneal abrasion and no signs of infection in the examination
  • Patients with lagophthalmos
  • Normal Controls

You may not qualify if:

  • Individuals with adhesive or tape allergies.
  • Individuals with a history of metal pieces/shavings embedded in the eye (such as from welding or metalworking)
  • Individuals with eye infections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Illinois - Specialty Care Building

Chicago, Illinois, 60612, United States

RECRUITING

MeSH Terms

Conditions

Lagophthalmos

Condition Hierarchy (Ancestors)

Eye ManifestationsEye DiseasesEyelid Diseases

Central Study Contacts

Pete Setabutr, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: temporary magnetic system for tarsorrhaphy (MST)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Oculoplastic & Reconstructive Surgery Service Director, Millennium Park Eye Center

Study Record Dates

First Submitted

January 26, 2024

First Posted

March 4, 2024

Study Start

April 17, 2024

Primary Completion

December 1, 2024

Study Completion

April 1, 2025

Last Updated

May 13, 2024

Record last verified: 2024-05

Locations